Inventor · disambiguated record
Daniel S. Allison
Also filed as: ALLISON DANIEL S · ALLISON DANIEL SCOTT · ALLISON DANIEL W
32 granted patents·9 pending applications·336 citations·filing 1997–2024
97Inventor score
Top patents by PatentIndex Score
41 records- 0197US11938185B2Treatment of headache, migraine and/or photophobia conditions using humanized anti-PACAP antibodiesH LUNDBECK AS·Filed 2020·Granted Mar 26, 2024·3 cites·42 claims
- 0296US5888809AHamster EF-1α transcriptional regulatory DNAICOS CORP·Filed 1997·Granted Mar 30, 1999·221 cites·29 claims
- 0395US12162936B2Methods of treatment with anti-PACAP antibodiesH LUNDBECK AS·Filed 2021·Granted Dec 10, 2024·2 cites·23 claims
- 0495US11993648B2Screening method for identifying anti-PACAP antibodies or antibody fragments suitable for use in treating or preventing PACAP-associated photophobia or light aversionH LUNDBECK AS·Filed 2020·Granted May 28, 2024·3 cites·9 claims
- 0595US10975135B2Humanized anti-PACAP antibodiesH LUNDBECK AS·Filed 2020·Granted Apr 13, 2021·4 cites·34 claims
- 0695US10968268B2Humanized anti-PACAP antibodiesH LUNDBECK AS·Filed 2020·Granted Apr 6, 2021·4 cites·34 claims
- 0795US10954285B2Humanized anti-PACAP antibodiesH LUNDBECK AS·Filed 2020·Granted Mar 23, 2021·4 cites·34 claims
- 0892US10533045B2Antibody purification and purity monitoringALDERBIO HOLDINGS LLC·Filed 2016·Granted Jan 14, 2020·12 cites·13 claims
- 0992US10202435B2Anti-PACAP antibodies and uses thereofALDER BIOPHARMACEUTICALS INC·Filed 2017·Granted Feb 12, 2019·9 cites·19 claims
- 1092US9518082B2Antibody purification and purity monitoringALDERBIO HOLDINGS LLC·Filed 2014·Granted Dec 13, 2016·16 cites·11 claims
- 1191US11427631B2Anti-ACTH antibodies and use thereofH LUNDBECK AS·Filed 2020·Granted Aug 30, 2022·2 cites·26 claims
- 1291US10981985B2Anti-PACAP antibodiesH LUNDBECK AS·Filed 2020·Granted Apr 20, 2021·2 cites·30 claims
- 1391US10981984B2Methods of determining whether anti-PACAP antibodies inhibit PACAP-associated photophobia or light aversionALDER BIOPHARMACEUTICALS INC·Filed 2018·Granted Apr 20, 2021·3 cites·9 claims
- 1491US10913783B2Humanized anti-PACAP antibodies and uses thereofALDER BIOPHARMACEUTICALS INC·Filed 2017·Granted Feb 9, 2021·4 cites·25 claims
- 1591US10844116B2Use of anti-pacap antibodies and antigen binding fragments thereof for treatment, prevention, or inhibition of photophobiaALDERBIO HOLDINGS LLC·Filed 2016·Granted Nov 24, 2020·3 cites·9 claims
- 1690US11254741B2Anti-PACAP antibodiesALDER BIOPHARMACEUTICALS INC·Filed 2019·Granted Feb 22, 2022·2 cites·20 claims
- 1790US2025009876A1Humanized anti-pacap antibodies and uses thereofH LUNDBECK AS·Filed 2024·Application pending·0 cites
- 1889US10899834B2Anti-PACAP antibodiesALDER BIOPHARMACEUTICALS INC·Filed 2016·Granted Jan 26, 2021·2 cites·20 claims
- 1988US11352409B2Anti-PACAP antibodies and uses thereofH LUNDBECK AS·Filed 2019·Granted Jun 7, 2022·2 cites·27 claims
- 2088US11117960B2Humanized anti-ACTH antibodies and use thereofALDERBIO HOLDINGS LLC·Filed 2019·Granted Sep 14, 2021·2 cites·26 claims
- 2186US10259885B2Anti-PCSK9 antibodies and use thereofALDERBIO HOLDINGS LLC·Filed 2015·Granted Apr 16, 2019·4 cites·21 claims
- 2285US9677070B2Composition and method for diversification of target sequencesOMEROS CORP·Filed 2013·Granted Jun 13, 2017·6 cites·28 claims
- 2385US9102724B2Anti-FZD10 monoclonal antibodies and methods for their useCUMMINGS W JASON·Filed 2012·Granted Aug 11, 2015·15 cites·19 claims
- 2483US10544214B2Humanized anti-ACTH antibodies and use thereofALDER BIOPHARMACEUTICALS INC·Filed 2018·Granted Jan 28, 2020·2 cites·20 claims
- 2582US12351627B2Anti-ACTH antibodies and use thereofH LUNDBECK AS·Filed 2022·Granted Jul 8, 2025·0 cites·13 claims
- 2681US12077581B2Anti-PACAP antibodies and uses thereofH LUNDBECK AS·Filed 2021·Granted Sep 3, 2024·0 cites·18 claims
- 2781US10550180B2Anti-ACTH antibodies and use thereofALDERBIO HOLDINGS LLC·Filed 2017·Granted Feb 4, 2020·2 cites·8 claims
- 2881US10047157B2Humanized anti-ACTH antibodies and use thereofALDER BIOPHARMACEUTICALS INC·Filed 2015·Granted Aug 14, 2018·2 cites·11 claims
- 2979US9688754B2Anti-ACTH antibodies and use thereofALDER BIOPHARMACEUTICALS INC·Filed 2015·Granted Jun 27, 2017·2 cites·8 claims
- 3078US12428475B2Humanized anti-ACTH antibodies and use thereofH LUNDBECK AS·Filed 2021·Granted Sep 30, 2025·0 cites·30 claims
- 3176US2021380676A1Methods of determining whether anti-pacap antibodies inhibit pacap-associated photophobia or light aversionH LUNDBECK AS·Filed 2021·Application pending·0 cites
- 3271US8609818B2Generation of anti-FN14 monoclonal antibodies by ex-vivo accelerated antibody evolutionLEPPARD JOHN BENJAMIN·Filed 2012·Granted Dec 17, 2013·2 cites·38 claims
- 3369US9346888B2Generation of anti-FN14 monoclonal antibodies by ex-vivo accelerated antibody evolutionOMEROS CORP·Filed 2013·Granted May 24, 2016·1 cites·20 claims
- 3457US2014287952A1Protocol for identifying and isolating antigen-specific b cells and producing antibodies to desired antigensALDERBIO HOLDINGS LLC·Filed 2014·Application pending·0 cites
- 3556US2016033504A1Protocol for identifying and isolating antigen-specific b cells and producing antibodies to desired antigensALDER BIOPHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3656US2008293105A1Recombinant method for making multimeric proteinsICOS CORP·Filed 2007·Application pending·0 cites
- 3753US2022306734A1Anti-mglur5 antibodies and uses thereofH LUNDBECK AS·Filed 2020·Application pending·0 cites
- 3852US2006121574A1Recombinant method for making multimeric proteinsICOS CORP·Filed 2005·Application pending·0 cites
- 3945US2004265880A1Genomic and proteomic approaches for the development of cell culture mediumSIGMA ALDRICH CO·Filed 2004·Application pending·0 cites
- 4042US9777065B2Anti-FZD10 monoclonal antibodies and methods for their useOMEROS CORP·Filed 2015·Granted Oct 3, 2017·0 cites·25 claims
- 4137US2018142038A1Anti-glycoprotein antibodies and uses thereofALDER BIOPHARMACEUTICALS INC A/B/A ALDERBIO HOLD HOLDINGS LLC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel S. Allison files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →